GUIDANCE OF GANCICLOVIR THERAPY WITH PP65 ANTIGENEMIA IN CYTOMEGALOVIRUS-FREE RECIPIENTS OF LIVERS FROM SEROPOSITIVE DONORS1
- 1 June 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 61 (11) , 1659,1660-1660
- https://doi.org/10.1097/00007890-199606150-00022
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- CLINICAL AND VIROLOGICAL MONITORING OF HUMAN CYTOMEGALOVTRUS INFECTION IN 294 HEART TRANSPLANT RECIPIENTSTransplantation, 1995
- Cytomegalovirus Immune Globulin Prophylaxis in Liver TransplantationAnnals of Internal Medicine, 1993
- Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement.Journal of Clinical Investigation, 1993
- Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.1993
- Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptanceHepatology, 1993
- Human Cytomegalovirus Infection of the Major Leukocyte Subpopulations and Evidence for Initial Viral Replication in Polymorphonuclear Leukocytes from Viremic PatientsThe Journal of Infectious Diseases, 1992
- DIRECT DETECTION OF CYTOMEGALOVIRUS IN PERIPHERAL BLOOD LEUKOCYTES-A REVIEW OF THE ANTIGENEMIA ASSAY AND POLYMERASE CHAIN REACTIONTransplantation, 1992
- Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cellsJournal of General Virology, 1991
- Preemptive Therapy in Immunocompromised HostsNew England Journal of Medicine, 1991
- Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patientsJournal of Medical Virology, 1989